Comments
Loading...
Intensity Therapeutics (NASDAQ:INTS) Stock, Earnings Estimates, EPS, And Revenue
Intensity Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.250
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Intensity Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Intensity Therapeutics (INTS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.25 | $-0.30 | 16.7 % |
| Jun 2024 | 2024-08-08 | $-0.36 | $-0.32 | -12.5 % |
| Dec 2023 | 2024-03-14 | $-0.12 | $-0.18 | 33.3 % |
| Sep 2023 | 2023-11-13 | $-0.17 | $-0.09 | -88.9 % |
Intensity Therapeutics (INTS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?
Intensity Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Intensity Therapeutics (NASDAQ:INTS)?
Intensity Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-0.25, which beat the estimate of $-0.30.
What were Intensity Therapeutics’s (NASDAQ:INTS) revenues?
Intensity Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.